首页> 外文期刊>Transplantation: Official Journal of the Transplantation Society >Is cystatin C useful for the detection and the estimation of low glomerular filtration rate in heart transplant patients?
【24h】

Is cystatin C useful for the detection and the estimation of low glomerular filtration rate in heart transplant patients?

机译:胱抑素C对检测和评估心脏移植患者肾小球滤过率低有用吗?

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Although previously studied in patients with chronic kidney disease, there is less data for the use of cystatin C and cystatin C-based formulas in heart transplant recipients. The ability of creatinine and cystatin C to detect renal failure (glomerular filtration rate [GFR] below 60 mL/min/1.73 m(2)) in heart transplant patients has been compared. The accuracy and precision of a creatinine-based formula (Modification of Diet in Renal Disease [MDRD]) versus a cystatin C-based formula (Rule's formula) to estimate GFR have also been studied. GFR was measured using the (51)Cr-ethylenediamine tetraacetic acid tracer in 27 patients. There was no significant difference between GFR and the reciprocal of creatinine or cystatin C. Receiver operating characteristic curves for cystatin C and creatinine were similar. Both formulas were well correlated with the GFR. The bias of the cystatin C-based was significantly better than one of the MDRD formula, but the standard deviation appeared better for the MDRD formula (bias of +3.9 mL/min/1.73 m(2) versus +12 mL/min/1.73 m(2) and SD of 8.5 versus 11.6, respectively). Plasma cystatin C has no clear advantage over serum creatinine to detect renal failure in heart transplanted patients.
机译:尽管以前曾在患有慢性肾脏疾病的患者中进行过研究,但在心脏移植受者中使用半胱氨酸蛋白酶抑制剂C和基于半胱氨​​酸蛋白酶抑制剂C的配方的数据较少。比较了肌酐和半胱氨酸蛋白酶抑制剂C在心脏移植患者中检测肾功能衰竭(肾小球滤过率[GFR]低于60 mL / min / 1.73 m(2))的能力。还研究了基于肌酸酐的公式(肾脏疾病饮食的修改[MDRD])与基于半胱氨​​酸蛋白酶抑制剂C的公式(Rule's公式)估算GFR的准确性和精确性。使用(51)Cr-乙二胺四乙酸示踪剂测量了27例患者的GFR。 GFR和肌酐或半胱氨酸蛋白酶抑制剂C的倒数之间无显着差异。半胱氨酸蛋白酶抑制剂C和肌酐的受体工作特性曲线相似。这两个公式均与GFR相关。基于半胱氨​​酸蛋白酶抑制剂C的偏差明显优于MDRD公式之一,但MDRD公式的标准偏差似乎更好(偏差为+3.9 mL / min / 1.73 m(2)与+12 mL / min / 1.73 m(2)和SD分别为8.5和11.6)。血浆半胱氨酸蛋白酶抑制剂C在检测心脏移植患者的肾衰竭方面与血清肌酐没有明显的优势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号